Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Perspective Therapeutics, Inc. (CATX) vs Standard BioTools Inc. (LAB)

Perspective Therapeutics, Inc. and Standard BioTools Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. and Standard BioTools Inc. are of similar size ($291.7M and $285.4M). Perspective Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 3.4×. Standard BioTools Inc. grew revenue faster over the last twelve months: 30.2% against −66.9%. Standard BioTools Inc. has the higher net margin (100.4% vs −28,468.0%) and the lower return on invested capital (−93.9% vs −88.4%). Across the 18 metrics below, Standard BioTools Inc. leads on 15 and Perspective Therapeutics, Inc. on 3.

Valuation

Metric CATX LAB Medical Devices median
P/E n/m 3.36 22.18
P/S 743.38 3.42 2.70
P/B 0.94 0.54 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 1.96 11.78
EV/Sales 167.98 (2.15) 2.38
Earnings yield (52.65%) 29.73% (8.22%)
Free cash flow yield (39.86%) (30.83%) (7.80%)

Profitability

Metric CATX LAB Medical Devices median
Gross margin 100.00% 50.49% 56.01%
Operating margin (30,619.07%) (112.85%) (15.03%)
Net margin (28,467.97%) 100.37% (20.40%)
Free cash flow margin (29,630.07%) (97.61%) (7.24%)
Return on equity (39.50%) 17.61% (15.32%)
Return on assets (33.14%) 14.34% (19.72%)
Return on invested capital (88.41%) (93.89%) (10.33%)

Growth

Metric CATX LAB Medical Devices median
Revenue growth (TTM) (66.88%) 30.23% 8.80%
EPS growth (last fiscal year) (13.82%) 61.54% —
Revenue growth, 5-year CAGR (38.04%) (9.19%) 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CATX LAB Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 6.61 9.10 2.50
Net debt to EBITDA 1.27 1.84 0.49

Dividend

Metric CATX LAB Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CATX LAB Medical Devices median
Market cap 285.38m 291.69m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack